First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

Core Connection: Electron Microscopy

October 23, 2017 | Katie Neith

At City of Hope’s Electron Microscopy Core Facility, researchers can take sharper, closer looks at the structural elements that form the human body at the nanoscale.

Core Connection: Get to Know the Integrative Genomics Core

July 6, 2017 | Katie Neith

At City of Hope, the Integrative Genomics Core (IGC) provides basic science, translational and clinical researchers with high-quality, efficient, comprehensive and cost-effective genomic services using microarray and high-throughput sequencing technologies.

Core Connection: Gene Editing and Viral Vector Core

January 12, 2017 | Katie Neith

A look at the Gene Editing and Viral Vector Core, one of City of Hope’s newest shared resources.